包括對心肌細胞和肝細胞進行基因測序及表觀遺傳分析在內的兩項干細胞合作項目12日在深圳啟動，以推進干細胞檢測方法在藥物發現和毒性測試中的應用。
Shenzhen (CNS) -- Two projects involving genomic sequencing and epigenetic inheritance analysis of cardiomyocytes and hepatic cells were launched on Tuesday, in order to promote the application of stem cell detection methods for drug inventions and toxicity tests.
The Beijing Genomics Institute and GE Healthcare Worldwide signed a cooperation agreement and plan for the two hi-tech projects.
The results are likely to lower the invention costs of safer classes of drugs by means of distinguishing predictable genomic cell models, said Dr. Amr Abid with the GE Healthcare.
Copyright ©1999-2011 Chinanews.com. All rights reserved.
Reproduction in whole or in part without permission is prohibited.
